Rituximab plus cyclophosphamide, doxorubicin, vincristine,...

The Lancet 2013 / 05 Vol. 381; Iss. 9880

Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles

Cunningham, David, Hawkes, Eliza A, Jack, Andrew, Qian, Wendi, Smith, Paul, Mouncey, Paul, Pocock, Christopher, Ardeshna, Kirit M, Radford, John A, McMillan, Andrew, Davies, John, Turner, Deborah, Kru
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
381
Language:
english
Journal:
The Lancet
DOI:
10.1016/S0140-6736(13)60313-X
Date:
May, 2013
File:
PDF, 429 KB
english, 2013
Conversion to is in progress
Conversion to is failed